Melinta Therapeutics granted marketing authorization for Vabomere in Europe Nov. 28, 2018 No Comments
FDA grants accelerated approval to Vitrakvi for advanced solid tumors with NTRK gene fusion Nov. 27, 2018 No Comments
FDA approves Daurismo for newly diagnosed AML ineligible for intensive chemotherapy Nov. 22, 2018 No Comments
FDA grants approval for Adcetris as first-line treatment for peripheral T-cell lymphoma Nov. 19, 2018 No Comments
European Commission approves Cabometyx for HCC previously treated with sorafenib Nov. 15, 2018 No Comments
RSS